Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 3 Study of Aripriprazole in the Treatment of Post-Traumatic Stress Disorder Symptoms

NCT00440713 is registered in ClinicalTrials.gov with Federal University of São Paulo as lead sponsor.

NCT NCT00440713
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00440713 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 3 Study of Aripriprazole in the Treatment of Post-Traumatic Stress Disorder Symptoms
Lead sponsor
Federal University of São Paulo
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2004
Completion date
March 31, 2006
Enrollment
40
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

posttraumatic stress disorder